Roivant Sciences Ltd. Purchase Agreements
5 Contracts & Agreements
- First Amendment to Revenue Interest Purchase and Sale Agreement by and among Dermavant Sciences GmbH, certain purchasers and U.S. Bank National Association as collateral agent,... (Filed With SEC on August 9, 2024)
- Common Shares Purchase Agreement, dated February 14, 2022, between Roivant Sciences Ltd. and CF Principal Investments LLC (Filed With SEC on February 14, 2022)
- First Amendment to the Asset Purchase Agreement, dated as of August 31, 2012, by and between Glaxo Group Limited and Welichem Biotech, Inc (Filed With SEC on May 14, 2021)
- Asset Purchase Agreement, dated as of May 29, 2012, by and between Glaxo Group Limited and Welichem Biotech Inc (Filed With SEC on May 14, 2021)
- Asset Purchase Agreement, dated as of July 10, 2018, by and among GlaxoSmithKline Intellectual Property Development Ltd., Glaxo Group Limited and Dermavant Sciences GmBH (Filed With SEC on May 14, 2021)
